Immunosuppressants

Psychosomatics

Volumn 43, Issue 5, 2002, Pages 424-427

  Armstrong, Scott C ^a   Cozza, Kelly L ^a   Pimentel, Elisabeth A ^a  

^a Tuality Forest Grove Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; DILTIAZEM; EFAVIRENZ; ERYTHROMYCIN; FLUCONAZOLE; FLUVOXAMINE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; KETOCONAZOLE; METHYLPREDNISOLONE; MIBEFRADIL; MODAFINIL; NEFAZODONE; NORFLOXACIN; OKT 3; ORAL CONTRACEPTIVE AGENT; PHENOBARBITAL; PHENYTOIN; PREDNISONE; RAPAMYCIN; RIFAMPICIN; RITONAVIR; TACROLIMUS;

CONSULTATION; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SAFETY; DRUG SCREENING; HUMAN; PSYCHIATRIST; REVIEW;

EID: 0036739864     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.43.5.424     Document Type: Article

References (31)

1. Horton RC, Bonser RS: Interaction between cyclosporin and fluoxetine. Br Med J 1995; 311:422
2. Page RL II, Ruscin JM, Fish D, Lapointe M: Possible interaction between intravenous azithromycin and oral cyclosporine. Pharmacotherapy 2001; 21:1436-1443
3. Armstrong SC, Cozza KL: Consultation-liaison psychiatry drug-drug interactions update. Psychosomatics 2001; 42:269-272
4. Theis JG, Chan HS, Grennberg MC, et al: Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin. Int J Clin Pharmacol Ther 1998; 36:61-64
5. Malingre MM, Richel DJ, Beijnen JH, et al: Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel. J Clin Oncol 2001; 19:1160-1166
6. Armstrong SC, Cozza KL: Consultation-liaison psychiatry drug-drug interactions update. Psychosomatics 1999; 40:275-276
7. Moore LW, Alloway RR, Acchiardo SR, et al: Clinical observations of metabolic changes occurring in renal transplant recipients receiving ketoconazole. Transplantation 1996; 6:537-541
8. Vella JP, Sayegh MH: Interactions between cyclosporine and newer antidepressant medications. Am J Kidney Dis 1998; 31:320-323
9. Wright DH, Lake KD, Bruhn PS, et al: Nefazodone and cyclosporine drug-drug interaction. J Heart Lung Transplant 1999; 18:913-915
10. Park JW, Siekmeier R, Lattke P, Merz M, Mix C, Schuler S, Jaross W: Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A. J Cardiovasc Pharmacol Ther 2001; 6:351-361
11. Armstrong SC, Cozza KL, Oesterheld JH: Med-psych drug-drug interactions update. Psychosomatics 2002; 43:77-81
12. Cooney GF, Mochon M, Kaiser B, et al: Effects of carbamazepine on cyclosporine metabolism in pediatric renal transplant recipients. Pharmacotherapy 1995; 15:353-356
13. Ernst E: St. John's wort supplements endanger the success of organ transplantation. Arch Surg 2002; 137:316-319
14. Armstrong SC, Cozza KL, Cole MA: Consultation-liaison psychiatry drug-drug interactions update. Psychosomatics 2000; 41:375-376
15. Boissonnat P, de Lorgeril M, Perroux V, et al: A drug interaction study between ticlopidine and cyclosporin in heart transplant recipients. Eur J Clin Pharmacol 1997; 53:39-45
16. Vasquez E, Pollak R, Benedetti E: Clotrimazole increases tacrolimus blood levels: a drug interaction in kidney transplant patients. Clin Transplant 2001; 15:95-99
17. Butani L, Berg G, Makker SP: Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient. Transplantation 2002; 73:159-160
18. Homma M, Itagaki F, Yuzawa K, et al: Effects of lanzoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation. Transplantation 2002; 73:303-304
19. Taber DJ, Dupuis RE, Hollar KD, et al: Drug-drug interaction between chloramphenicol and tacrolimus in a liver transplant recipient. Transplantation Proceedings 2000; 32:660-662
20. Kotanko P, Kirisits W, Skrabal F: Rhabdomyolosis and acute renal graft impairment in a patient treated with simvastatin, tacrolimus and fusidic acid. Nephron 2002; 90:234-235
21. Vasquez EM, Pollak R: OKT3 therapy increases cyclosporine blood levels. Clin Transplant 1997; 11:38-41
22. Gornet JM, Lokiec F, Duclos-Vallee JC, et al: Severe CPT-11-induced diarrhea in the presence of FK-506 following liver transplantation for hepatocellular injury. Anticancer Res 2001; 21(6A):4203-4206
23. Masuda S, Uemoto S, Hashida T, et al: Effect of intestinal P-glycoprotein on daily tacrolimus trough level in living-donor small bowel recipient. Clin Pharmacol Ther 2000; 68:98-103
24. Chenhsu RY, Loong CC, Chou MH, et al: Renal allograft dysfunction associated with rifampin-tacrolimus interaction. Ann Pharmacotherapy 2000; 34:27-31
25. Bolley R, Zulke C, Kammerl M, et al: Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St. John's wort. Transplantation 2002; 73:1009
26. Mahalati K, Kahan BD: Clinical pharmacokinetics of sirolimus. Clin Pharmacokinet 2001; 40:573-585
27. Böttiger Y, Säwe J, Brattström C, et al: Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers. Clin Pharmacol Ther 2001; 69:32-40
28. Lo A, Burckart GJ: P-glycoprotein and drug therapy in organ transplantation. J Clin Pharmacol 1999; 39:995-1005
29. Imani S, Jusko WJ, Steiner R: Diltiazem retards the metabolism of oral prednisone with effects on T-cell markers. Pediatr Transplant 1999; 3:126-130
30. Lebrun-Vignes B, Archer VC, Diquet B, et al: Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and corticol secretion in healthy subjects. J Clin Pharmacol 2001; 51:443-450
31. Varis T, Backman JT, Kivistö KT, et al: Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone. Clin Pharmacol Ther 2000; 67:215-221